share_log

Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market

Benzinga ·  12/06/2023 21:08

Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment